Last week, LIC reported a 23 per cent jump in net profit to record Rs 23,420 crore in the just concluded March quarter as compared to Rs 19...

Life Insurance Corporation of India has achieved the highest profit in the Indian financial sector for the March quarter. The company repor...

Aadhar Housing Finance reported 27% Q4 profit growth to Rs 311 crore, driven by strong loan disbursements and business expansion. Assets un...

Bandhan Bank reported a 68% YoY jump in Q4 profit to ₹530 crore, driven by sharply lower provisions and improved asset quality. NII growth ...

Mahindra & Mahindra Financial Services shares jumped 10% after a strong Q4 performance, with net profit rising 55% YoY to Rs 873 crore. Gro...

Indian Energy Exchange delivered steady quarterly growth driven by record electricity trading volumes, improving revenue and profit, alongs...

HDB Financial Q4 Results: HDB Financial on Wednesday reported a 41% year-on-year spike in its Q4 profit at Rs 751 crore from Rs 531 crore a...

The decline in bottomline came despite a 25 per cent on-year fall in tax expenses and 67 per cent jump in other income during the reported ...

The lender is likely to report 77 per cent year-on-year growth in net profit to Rs 4,596 crore for the quarter ended June, according to a p...

The strong bottomline performance of the lender was aided by a 41 per cent on-year fall in provisions during the reported quarter.

ITC posted a 4 per cent increase in net profit – the slowest growth in the past 11 quarters.

We expect corporates to report a topline growth ranging from 10 to 12 per cent in the March quarter, while the bottomline may surpass topli...

An improving operating margin profile since the past couple of quarters has been fuelling expectations of a smart recovery in TGB's perform...

While ITC’s revenues grew 25% - the highest quarterly growth in the last four years, its net profit grew 15.6% - the lowest in the last fiv...

Sintex Industries reported a strong operational performance for the December '12 quarter with improving sales as well as margins.

The launch of Combivir generic is a positive development for Lupin. However, it will have to share the mkt with competitors viz. Teva & Aur...

Angel Broking has maintain a ‘Buy’ on Zensar Technologies, with a 12-month target price of Rs 280, which has been downgraded by 7 per cent ...